Literature DB >> 15889232

Dysregulation of energy homeostasis in mice overexpressing insulin-like growth factor-binding protein 6 in the brain.

G Bienvenu1, D Seurin, Y Le Bouc, P Even, S Babajko, C Magnan.   

Abstract

AIMS/HYPOTHESIS: IGFs, IGF receptors and IGF binding proteins (IGFBPs) are widely expressed in the central nervous system. To investigate the physiological significance of IGFBP-6 in the brain we established two transgenic mouse lines overexpressing human (h)-IGFBP-6 under the control of glial fibrillary acidic protein promoter. Increasing evidence suggests that insulin/IGF signalling pathways could be implicated in the neuroendocrine regulation of energy homeostasis. We explored the impact of brain IGFBP-6 overexpression on the regulation of food intake and energy balance.
METHODS: Transgenic mice were fed either a control diet or a high-fat diet for up to 3 months. Glucose and insulin tolerance tests were carried out before and after the diet period. Plasma parameters (insulin, leptin, glucose, NEFAs and triglycerides) were measured, and uncoupling protein 1 (UCP-1) expression was quantified in brown adipose tissue. Oxygen consumption was also measured in both groups.
RESULTS: The transgenic mice fed a high-fat diet for 3 months developed obesity, showing increases in plasma leptin, glucose and insulin levels and mild insulin resistance. As compared with wild-type mice, no significant differences were found in the quantity of food intake. However, UCP-1 expression was down-regulated in the brown adipose tissue of the transgenic mice. CONCLUSIONS/
INTERPRETATION: Our results show that brain IGFBP-6 has an impact on the regulation of energy homeostasis. These transgenic h-IGFBP-6 mice may be considered a new tool for studies of the involvement of the brain IGF system in metabolism control and obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15889232     DOI: 10.1007/s00125-005-1767-6

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

Review 1.  The insulin-like growth factor-binding protein (IGFBP) superfamily.

Authors:  V Hwa; Y Oh; R G Rosenfeld
Journal:  Endocr Rev       Date:  1999-12       Impact factor: 19.871

2.  Overexpression of insulin-like growth factor binding protein-5 helps accelerate progression to androgen-independence in the human prostate LNCaP tumor model through activation of phosphatidylinositol 3'-kinase pathway.

Authors:  H Miyake; C Nelson; P S Rennie; M E Gleave
Journal:  Endocrinology       Date:  2000-06       Impact factor: 4.736

Review 3.  The role of the insulin-like growth factor system in the developing brain.

Authors:  G A Werther; V Russo; N Baker; G Butler
Journal:  Horm Res       Date:  1998

4.  Food intake and serum insulin responses to intraventricular infusions of insulin and IGF-I.

Authors:  L A Foster; N K Ames; R S Emery
Journal:  Physiol Behav       Date:  1991-10

Review 5.  Insulin-like growth factor binding proteins and their role in controlling IGF actions.

Authors:  D R Clemmons
Journal:  Cytokine Growth Factor Rev       Date:  1997-03       Impact factor: 7.638

Review 6.  Practical aspects of indirect calorimetry in laboratory animals.

Authors:  P C Even; A Mokhtarian; A Pele
Journal:  Neurosci Biobehav Rev       Date:  1994       Impact factor: 8.989

7.  Intermediate filaments modulation in an in vitro model of the hepatic stellate cell activation or conversion into the lipocyte phenotype.

Authors:  T G Mello; C S Mermelstein; V A Fortuna; S T Wofchuk; C Gottfried; R M Guaragna; M L Costa; R Borojevic
Journal:  Biochem Cell Biol       Date:  2001       Impact factor: 3.626

8.  GFAP Transgenic Mice

Authors: 
Journal:  Methods       Date:  1996-12       Impact factor: 3.608

9.  The insulin-like growth factor I system in the rat cerebellum: developmental regulation and role in neuronal survival and differentiation.

Authors:  I Torres-Aleman; S Pons; M A Arévalo
Journal:  J Neurosci Res       Date:  1994-10-01       Impact factor: 4.164

10.  Expression of IGF-I and -II mRNA in the brain and craniofacial region of the rat fetus.

Authors:  C Ayer-le Lievre; P A Ståhlbom; V R Sara
Journal:  Development       Date:  1991-01       Impact factor: 6.868

View more
  6 in total

1.  Altered metabolism and resistance to obesity in long-lived mice producing reduced levels of IGF-I.

Authors:  Adam B Salmon; Chad Lerner; Yuji Ikeno; Susan M Motch Perrine; Roger McCarter; Christian Sell
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-02-03       Impact factor: 4.310

Review 2.  Mice with gene alterations in the GH and IGF family.

Authors:  Yanrong Qian; Darlene E Berryman; Reetobrata Basu; Edward O List; Shigeru Okada; Jonathan A Young; Elizabeth A Jensen; Stephen R C Bell; Prateek Kulkarni; Silvana Duran-Ortiz; Patricia Mora-Criollo; Samuel C Mathes; Alison L Brittain; Mat Buchman; Emily Davis; Kevin R Funk; Jolie Bogart; Diego Ibarra; Isaac Mendez-Gibson; Julie Slyby; Joseph Terry; John J Kopchick
Journal:  Pituitary       Date:  2021-11-19       Impact factor: 4.107

3.  A model of insulin resistance in mice, born to diabetic pregnancy, is associated with alterations of transcription-related genes in pancreas and epididymal adipose tissue.

Authors:  Akadiri Yessoufou; Kabirou Moutairou; Naim Akhtar Khan
Journal:  J Obes       Date:  2010-09-26

4.  Intermittent hypoxia exacerbates pancreatic β-cell dysfunction in a mouse model of diabetes mellitus.

Authors:  Shariq I Sherwani; Carolyn Aldana; Saif Usmani; Christopher Adin; Sainath Kotha; Mahmood Khan; Timothy Eubank; Philipp E Scherer; Narasimham Parinandi; Ulysses J Magalang
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

5.  Central IGF1 improves glucose tolerance and insulin sensitivity in mice.

Authors:  Hao Hong; Zhen-Zhong Cui; Lu Zhu; Shu-Ping Fu; Mario Rossi; Ying-Hong Cui; Bing-Mei Zhu
Journal:  Nutr Diabetes       Date:  2017-12-19       Impact factor: 5.097

Review 6.  The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes.

Authors:  Natalie J Haywood; Thomas A Slater; Connor J Matthews; Stephen B Wheatcroft
Journal:  Mol Metab       Date:  2018-10-24       Impact factor: 7.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.